Unlocking the biology of RAGE in diabetic microvascular complications

102Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

Abstract

The discovery of the receptor for advanced glycation end-products (RAGE) set the stage for the elucidation of important mechanisms underpinning diabetic complications. RAGE transduces the signals of advanced glycation end-products (AGEs), proinflammatory S100/calgranulins, and high mobility group box 1 (HMGB1), and is a one of a family of receptors for lysophosphatidic acid (LPA). These ligand tales weave a theme of vascular perturbation and inflammation linked to the pathogenesis of the chronic complications of diabetes. Once deemed implausible, this concept of inflammatory cues participating in diabetic complications is now supported by a plethora of experimental evidence in the macro- and microvasculature. We review the biology of ligand-RAGE signal transduction and its roles in diabetic microvascular complications, from animal models to human subjects. © 2013 Elsevier Ltd.

Cite

CITATION STYLE

APA

Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M. (2014, January). Unlocking the biology of RAGE in diabetic microvascular complications. Trends in Endocrinology and Metabolism. https://doi.org/10.1016/j.tem.2013.08.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free